User:Y-S.Ko/Wikipedia course/Pharmacology/L-V
From Wikipedia, the free encyclopedia
| CI monoclonal antibodies ("-mab") |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Tyrosine kinase inhibitors ("-nib") |
| ||||||||
| Other |
| ||||||||
| Endogenous |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exogenous | |||||||||||||
| Intracellular (initiation) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracellular (reception) |
| ||||||||||||||
| Extracellular |
| ||||||||||||||
| Unsorted |
| ||||||||||||||
| pyrazolones / pyrazolidines | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
Specific antirheumatic products / DMARDs (M01C) | |
|---|---|
| Quinolines | |
| Gold preparations | |
| Other | |
| |
| Anti-inflammatory preparations, non-steroids |
| ||||||
|---|---|---|---|---|---|---|---|
| Capsaicin derivatives | |||||||
| Other | |||||||
Skeletal muscle relaxants (M03) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peripherally acting (primarily antinicotinic, NMJ block) |
| ||||||||||||||
| Centrally acting |
| ||||||||||||||
| Directly acting | |||||||||||||||
| Uricosurics |
| ||||
|---|---|---|---|---|---|
| Xanthine oxidase inhibitors |
| ||||
| Mitotic inhibitors | |||||
| Other | |||||
| |||||
Drugs for treatment of bone diseases (M05) | |
|---|---|
| Bisphosphonates | |
| Bone morphogenetic proteins | |
| Other |
|
Other drugs for disorders of the musculo-skeletal system (M09) | |
|---|---|
| Quinine and derivatives | |
| Enzymes | |
| Gene therapies | |
| Antisense oligonucleotides | |
| Glucocorticoids | |
| Histone deacetylase inhibitors | |
| Other | |
| |
| Inhalational | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injection |
| ||||||||||||||
| |||||||||||||||
| Esters by acid |
| ||||||
|---|---|---|---|---|---|---|---|
| Amides | |||||||
| Combinations | |||||||
| |||||||
| Opioids |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paracetamol-type | |||||||||||||||||
| NSAIDs |
| ||||||||||||||||
| Cannabinoids | |||||||||||||||||
| Ion channel modulators |
| ||||||||||||||||
| Myorelaxants | |||||||||||||||||
| Others | |||||||||||||||||
| |||||||||||||||||
Antimigraine preparations (N02C) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analgesic/abortive |
| ||||||||||||||||
| Prophylactic |
| ||||||||||||||||
| |||||||||||||||||
| GABAergics |
| ||||||
|---|---|---|---|---|---|---|---|
| Channel modulators |
| ||||||
| Others |
| ||||||
| |||||||
| Dopaminergics |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Anticholinergics | |||||||||||
| Others | |||||||||||
| |||||||||||
| D1-like |
| ||||||
|---|---|---|---|---|---|---|---|
| D2-like |
| ||||||
| Typical |
|
|---|---|
| Disputed | |
| Atypical | |
| Others |
|
| |
| 5-HT1ARTooltip 5-HT1A receptor agonists | |
|---|---|
| GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators |
|
| Hypnotics | |
| Gabapentinoids (α2δ VDCC blockers) | |
| Antidepressants |
|
| Antipsychotics | |
| Sympatholytics (Antiadrenergics) |
|
| Others | |
| |
| GABAA |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GABAB | |||||||||||||||||||||||||
| H1 |
| ||||||||||||||||||||||||
| α2-Adrenergic | |||||||||||||||||||||||||
| 5-HT2A |
| ||||||||||||||||||||||||
| Melatonin | |||||||||||||||||||||||||
| Orexin | |||||||||||||||||||||||||
| α2δ VDCC | |||||||||||||||||||||||||
| Others | |||||||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
N06BA Centrally acting sympathomimetics | |||||||||
|---|---|---|---|---|---|---|---|---|---|
N06BC Xanthine derivatives | |||||||||
N06BX Other psychostimulants and nootropics | |||||||||
| |||||||||
| AChE inhibitor medications | |
|---|---|
| Other medications | |
| Experimental BACE inhibitors | |
| |||||||||||||||||||||||||
Treatment of drug dependence (N07B) | |
|---|---|
| Nicotine dependence |
|
| Alcohol dependence | |
| Opioid dependence | |
| Benzodiazepine dependence |
|
Other nervous system drugs (N07X) | |
|---|---|
| Stroke | |
| ALS | |
| Other | |
| |
| Alveo- late |
| ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stramen- opile | |||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||
| Discicristata |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trichozoa |
| ||||||||||
| |||||||||||
| Entamoeba |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acanthamoeba | |||||||||||||||||
| |||||||||||||||||
| Antiplatyhelmintic agents |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antinematodal agents (including macrofilaricides) |
| ||||||||||||||
| |||||||||||||||
| Insecticide/pediculicide |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acaricide/miticide/scabicide |
| ||||||||||||||
| |||||||||||||||
| Carbamates | |
|---|---|
| Inorganic compounds | |
| Insect growth regulators | |
| Neonicotinoids | |
| Organochlorides | |
| Organophosphorus |
|
| Pyrethroids |
|
| Ryanoids | |
| Other chemicals |
|
| Metabolites | |
| Biopesticides | |
Decongestants and other nasal preparations (R01) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical |
| ||||||||||
| Systemic use: Sympathomimetics | |||||||||||
| |||||||||||
| Adrenergics, inhalants |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Glucocorticoids | |||||||||
| Anticholinergics/ muscarinic antagonist | |||||||||
| Mast cell stabilizers | |||||||||
| Xanthines | |||||||||
| Eicosanoid inhibition |
| ||||||||
| Others/unknown | |||||||||
| Combination products |
| ||||||||
| |||||||||
| Expectorants | |||||
|---|---|---|---|---|---|
| Mucolytics | |||||
| Cough suppressants |
| ||||
| |||||
| Benzimidazoles (*) | |
|---|---|
| Diarylmethanes |
|
| Ethylenediamines | |
| Tricyclics | |
| Others |
|
| For topical use | |
Other respiratory system products (R07) | |
|---|---|
| Lung surfactants | |
| Respiratory stimulants | |
| 5-HT4 receptor agonists | |
| Other agents for treating respiratory depression | |
| Antibiotics |
|
|---|---|
| Sulfonamides | |
| Antivirals | |
| Other | |
| Sympathomimetics | |||||||
|---|---|---|---|---|---|---|---|
| Parasympathomimetics |
| ||||||
| Carbonic anhydrase inhibitors/ (sulfonamides) | |||||||
| Beta blocking agents | |||||||
| Prostaglandin analogues (F2α) | |||||||
| Other agents | |||||||
| Antineovascularisation agents | |
|---|---|
| Nervous system |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Circulatory system |
| ||||||||||||||
| Other |
| ||||||||||||||
| Emetic | |||||||||||||||
| |||||||||||||||
| Copper | |
|---|---|
| Iron | |
| Lead | |
| Thallium | |
| Other | |
| |
| Folic acid / methotrexate |
|
|---|---|
| Uric acid (TLS) | |
| Acrolein / nitrogen mustards | |
| Iron / anthracyclines | |
| Alkylating agents | |
| Keratinocyte growth factor | |
| Other | |
| Treatment of hypercalcemia | |
|---|---|
| Treatment of hypoglycaemia | |
| Medical gases | |
Diagnostic agents (V04) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Digestive system |
| ||||||||||||
| Endocrine system |
| ||||||||||||
| Tuberculosis | |||||||||||||
| Renal function | |||||||||||||
| X-ray and CT |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI |
| ||||||||||||
| Ultrasound |
| ||||||||||||
| |||||||||||||
Diagnostic radiopharmaceuticals (V09) | |||||
|---|---|---|---|---|---|
| Central nervous system | |||||
| Skeletal system | |||||
| Renal | |||||
| Gastrointestinal/Hepatic | |||||
| Respiratory system | |||||
| Cardiovascular system | |||||
| Inflammation/infection | |||||
| Tumor | |||||
| Adrenal cortex |
| ||||
| Radionuclides (including tracers) |
| ||||
Therapeutic radiopharmaceuticals (V10) | |||||
|---|---|---|---|---|---|
| Pain palliation | |||||
| Adrenergic tumors | |||||
| CD20 antibodies | |||||
| Radionuclides |
| ||||